Trial Condition(s):

Acute Exacerbation Of Chronic Bronchitis, Community Acquired Pneumonia, Pelvic Inflammatory

Concentrations of moxifloxacin in gynecological tissues after single i.v. infusion of 400 mg in patients undergoing elective gynecological surgery

Bayer Identifier:

11134

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
43
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Avelox (Moxifloxacin hydrochloride, BAY12-8039)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Klinikum der Eberhard-Karls-Universität Tübingen

Tübingen, Germany, 72076

Status
Completed
 
Locations

CRS Clinical-Research-Services Kiel GmbH

Kiel, Germany, 24105

Status
Completed
 
Locations

Klinikum der Eberhard-Karls-Universität Tübingen

Tübingen, Germany, 72076

Status
Terminated
 

For details, please refer to trial results

Additional Information